financetom
Business
financetom
/
Business
/
Potomac Bancshares Q3 profit rises on higher interest income
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Potomac Bancshares Q3 profit rises on higher interest income
Oct 29, 2025 4:40 AM

Overview

* Potomac Bancshares ( PTBS ) Q3 net income rises 32% yr/yr, driven by revenue growth and margin expansion

* Company announces stock repurchase plan for up to 100,000 shares or $2.0 mln

* Bank of Charles Town to be renamed Potomac Bank

Outlook

* Company plans to expand business lines and leverage technology for client experiences

* Potomac Bancshares ( PTBS ) did not provide specific financial guidance for future quarters

Result Drivers

* NET INTEREST INCOME - Increased by $430k due to growth in earning assets and higher net interest margin

* NONINTEREST INCOME - Rose by $148k primarily due to higher wealth and investment income, and gains on mortgage loan sales

* ASSET QUALITY - Maintained strong asset quality with NPAs at 0.22% of total assets

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net 3.54%

Interest

Margin

Q3 $7.35

Provisio mln

n for

Credit

Losses

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints
Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints
Dec 20, 2024
* Data wipes $125 billion from Novo's market value * CagriSema is Novo's next-gen obesity drug candidate after Wegovy * Novo had expected weight loss of 25% * Novo exec says 'encouraged' by data By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN, Dec 20(Reuters) - Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped patients cut their weight...
Gatos Silver Amends Los Gatos JV Agreements With Dowa Metals and Mining
Gatos Silver Amends Los Gatos JV Agreements With Dowa Metals and Mining
Dec 20, 2024
06:38 AM EST, 12/20/2024 (MT Newswires) -- Gatos Silver ( GATO ) late on Thursday said it has amended its joint venture agreements with Dowa Metals and Mining, effective Jan. 1, to expand Gatos' management rights within the Los Gatos joint venture. The amendments allow Gatos to fully consolidate the financial statements of the Los Gatos JV rather than accounting...
Bank of Japan Will
Bank of Japan Will "Wait Till The Time Is Right" to Hike Rates, Says UBS
Dec 20, 2024
06:33 AM EST, 12/20/2024 (MT Newswires) -- The Bank of Japan (BoJ) held its policy rate unchanged at 0.25% this week, noted UBS. Given the uncertainty in the United States economy and politics, and about wage growth in Japan, the BoJ seems in no hurry to raise policy rates, wrote the bank in a note to clients. Governor Kazuo Ueda...
UK watchdog says $35 bln Synopsys-Ansys deal raises competition concerns
UK watchdog says $35 bln Synopsys-Ansys deal raises competition concerns
Dec 20, 2024
Dec 20 (Reuters) - UK's competition watchdog said on Friday chip design software maker Synopsys' ( SNPS ) $35 billion acquisition of Ansys ( ANSS ) could reduce innovation and lead to higher prices but that it could approve the deal if those concerns are resolved. The Competition and Markets Authority (CMA) said after its initial Phase 1 probe that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved